【Description】
The global market for Respiratory Infectious Disease Diagnostics was estimated to be worth US$ 8123 million in 2025 and is projected to reach US$ 11252 million, growing at a CAGR of 4.9% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Respiratory Infectious Disease Diagnostics cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
呼吸器感染症診断―グローバル市場シェアとランキング、全体の売上と需要予測、2026～2032
Key Market Statistics
Pre-Measurement Period
2025Year~2032Year
2025Year Evaluation
8123US$ M
2026Year Evaluation
8469US$ M
2032Year Evaluation
11252US$ M
Respiratory Infectious Disease Diagnostics refers to an in-vitro diagnostic product and technology system used to detect, identify, type, and clinically interpret viruses, bacteria, mycoplasma, chlamydia, and related immune-response markers in samples such as nasopharyngeal swabs, oropharyngeal swabs, nasal secretions, sputum, bronchoalveolar lavage fluid, and serum. It covers nucleic acid testing, antigen testing, antibody testing, lateral-flow immunoassays, fluorescent PCR, isothermal amplification, sequencing, multiplex panels, automated testing platforms, and laboratory information management. It is mainly used for the differential diagnosis of influenza, COVID-19, respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus, Mycoplasma pneumoniae, Chlamydia pneumoniae, and bacterial respiratory infections. Its core value lies in enabling rapid clinical triage, precise medication, infection control, severe-case early warning, and public health surveillance, making it a critical infrastructure linking clinical efficiency with infectious disease control capability.In 2025, global Respiratory Infectious Disease Diagnostics production reached approximately 1430.87 m units, with an average global market price of around US$ 5.68 perunit.The average gross profit margin of this product is 55%.
Respiratory infectious disease diagnostics is shifting from emergency testing during the pandemic toward a long-term market driven by routine use, seasonality, multiplex pathogen detection, and clinical pathway integration. Influenza, COVID-19, respiratory syncytial virus, Mycoplasma pneumoniae, human metapneumovirus, adenovirus, and other pathogens show alternating prevalence, mixed infections, and population-specific differences, making symptom-based differentiation insufficient for rapid diagnosis. This drives hospitals, public health agencies, independent clinical laboratories, and primary healthcare institutions to continuously strengthen precise testing capabilities. Corporate annual reports show that global diagnostic leaders have incorporated respiratory pathogen testing into their core molecular and rapid diagnostic portfolios, while government public health systems continue to strengthen sentinel surveillance, fever clinics, infectious disease departments, and laboratory testing capacity. Multiplex panels, rapid turnaround, automation-platform compatibility, and scenario expansion from hospital diagnosis to regional surveillance will become important drivers for industry value reassessment.The key challenges in respiratory infectious disease diagnostics come from pathogen prevalence fluctuations, pricing pressure, regulatory access requirements, technology iteration, and product homogenization. After the pandemic, demand for single-pathogen testing has returned to a more normalized level, requiring companies to shift toward syndromic diagnosis covering influenza, RSV, mycoplasma, bacteria, and viral combinations. Nucleic acid testing requires high sensitivity, specificity, contamination control, and laboratory workflow capability, while antigen and rapid testing must balance speed, cost, sample adaptability, and accuracy. Because respiratory infections are highly seasonal and sometimes sudden, companies also face pressure in capacity planning, inventory management, channel response, and stable raw-material supply. Future competition will not be limited to price, but will depend on clinical evidence, test menus, platform compatibility, supply-chain resilience, and public health response capability.Downstream demand is moving from “whether testing is available” to “whether multiple pathogens can be rapidly and accurately distinguished in a single workflow.” Emergency departments, pediatrics, respiratory medicine, infectious disease departments, and intensive care units in large hospitals need rapid triage and precise medication support to shorten diagnostic time, reduce empirical anti-infective therapy, and optimize ward management. Primary healthcare institutions focus more on rapid tests that are easy to operate, intuitive in results, and short in turnaround time for the initial screening of fever, cough, and influenza-like cases. Independent clinical laboratories emphasize batch testing and automated workflows, while public health systems focus on pathogen-spectrum monitoring, regional epidemic trends, and early warning. As tiered diagnosis, infection control, and infectious disease surveillance systems improve, respiratory infectious disease diagnostics will become a key link among hospital diagnosis, primary screening, and public health control.
This report provides a comprehensive view of the global market for Respiratory Infectious Disease Diagnostics, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Respiratory Infectious Disease Diagnostics market size, estimations, and forecasts are presented in terms of sales volume (M Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Respiratory Infectious Disease Diagnostics.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Respiratory Infectious Disease Diagnostics manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Respiratory Infectious Disease Diagnostics sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Respiratory Infectious Disease Diagnostics sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
【Table of Contents】
1 Market Overview
1.1 Respiratory Infectious Disease Diagnostics Product Introduction
1.2 Global Respiratory Infectious Disease Diagnostics Market Size Forecast
1.2.1 Global Respiratory Infectious Disease Diagnostics Sales Value (2021–2032)
1.2.2 Global Respiratory Infectious Disease Diagnostics Sales Volume (2021–2032)
1.2.3 Global Respiratory Infectious Disease Diagnostics Sales Price (2021–2032)
1.3 Respiratory Infectious Disease Diagnostics Market Trends & Drivers
1.3.1 Respiratory Infectious Disease Diagnostics Industry Trends
1.3.2 Respiratory Infectious Disease Diagnostics Market Drivers & Opportunities
1.3.3 Respiratory Infectious Disease Diagnostics Market Challenges
1.3.4 Respiratory Infectious Disease Diagnostics Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Respiratory Infectious Disease Diagnostics Players Revenue Ranking (2025)
2.2 Global Respiratory Infectious Disease Diagnostics Revenue by Company (2021–2026)
2.3 Global Respiratory Infectious Disease Diagnostics Sales Volume Ranking of Players (2025)
2.4 Global Respiratory Infectious Disease Diagnostics Sales Volume by Company (2021–2026)
2.5 Global Respiratory Infectious Disease Diagnostics Average Price by Company (2021–2026)
2.6 Key Manufacturers Respiratory Infectious Disease Diagnostics Manufacturing Base and Headquarters
2.7 Key Manufacturers Respiratory Infectious Disease Diagnostics Product Offerings
2.8 Key Manufacturers Start of Mass Production of Respiratory Infectious Disease Diagnostics
2.9 Respiratory Infectious Disease Diagnostics Market Competitive Analysis
2.9.1 Respiratory Infectious Disease Diagnostics Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Respiratory Infectious Disease Diagnostics Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Respiratory Infectious Disease Diagnostics revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Respiratory Infectious Disease Diagnostics Market Classification
3.1 Introduction by Type
3.1.1 Nucleic Acid Testing
3.1.2 Antigen Testing
3.1.3 Antibody Testing
3.1.4 Global Respiratory Infectious Disease Diagnostics Sales Value by Type
3.1.4.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Respiratory Infectious Disease Diagnostics Sales Value, by Type (2021–2032)
3.1.4.3 Global Respiratory Infectious Disease Diagnostics Sales Value, by Type (%), 2021–2032
3.1.5 Global Respiratory Infectious Disease Diagnostics Sales Volume by Type
3.1.5.1 Global Respiratory Infectious Disease Diagnostics Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Respiratory Infectious Disease Diagnostics Sales Volume, by Type (2021–2032)
3.1.5.3 Global Respiratory Infectious Disease Diagnostics Sales Volume, by Type (%), 2021–2032
3.1.6 Global Respiratory Infectious Disease Diagnostics Average Price by Type (2021–2032)
3.2 Introduction by Sample
3.2.1 Throat Swab
3.2.2 Nasal Swab
3.2.3 Sputum
3.2.4 Other
3.2.5 Global Respiratory Infectious Disease Diagnostics Sales Value by Sample
3.2.5.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Sample (2021 vs 2025 vs 2032)
3.2.5.2 Global Respiratory Infectious Disease Diagnostics Sales Value, by Sample (2021–2032)
3.2.5.3 Global Respiratory Infectious Disease Diagnostics Sales Value, by Sample (%), 2021–2032
3.2.6 Global Respiratory Infectious Disease Diagnostics Sales Volume by Sample
3.2.6.1 Global Respiratory Infectious Disease Diagnostics Sales Volume by Sample (2021 vs 2025 vs 2032)
3.2.6.2 Global Respiratory Infectious Disease Diagnostics Sales Volume, by Sample (2021–2032)
3.2.6.3 Global Respiratory Infectious Disease Diagnostics Sales Volume, by Sample (%), 2021–2032
3.2.7 Global Respiratory Infectious Disease Diagnostics Average Price by Sample (2021–2032)
3.3 Introduction by Testing Type
3.3.1 Single Detection
3.3.2 Multiple Detection
3.3.3 Global Respiratory Infectious Disease Diagnostics Sales Value by Testing Type
3.3.3.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Testing Type (2021 vs 2025 vs 2032)
3.3.3.2 Global Respiratory Infectious Disease Diagnostics Sales Value, by Testing Type (2021–2032)
3.3.3.3 Global Respiratory Infectious Disease Diagnostics Sales Value, by Testing Type (%), 2021–2032
3.3.4 Global Respiratory Infectious Disease Diagnostics Sales Volume by Testing Type
3.3.4.1 Global Respiratory Infectious Disease Diagnostics Sales Volume by Testing Type (2021 vs 2025 vs 2032)
3.3.4.2 Global Respiratory Infectious Disease Diagnostics Sales Volume, by Testing Type (2021–2032)
3.3.4.3 Global Respiratory Infectious Disease Diagnostics Sales Volume, by Testing Type (%), 2021–2032
3.3.5 Global Respiratory Infectious Disease Diagnostics Average Price by Testing Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinical Laboratories
4.1.3 Others
4.2 Global Respiratory Infectious Disease Diagnostics Sales Value by Application
4.2.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Respiratory Infectious Disease Diagnostics Sales Value, by Application (2021–2032)
4.2.3 Global Respiratory Infectious Disease Diagnostics Sales Value, by Application (%), 2021–2032
4.3 Global Respiratory Infectious Disease Diagnostics Sales Volume by Application
4.3.1 Global Respiratory Infectious Disease Diagnostics Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Respiratory Infectious Disease Diagnostics Sales Volume, by Application (2021–2032)
4.3.3 Global Respiratory Infectious Disease Diagnostics Sales Volume, by Application (%), 2021–2032
4.4 Global Respiratory Infectious Disease Diagnostics Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Region
5.1.1 Global Respiratory Infectious Disease Diagnostics Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Respiratory Infectious Disease Diagnostics Sales Value by Region (2021–2026)
5.1.3 Global Respiratory Infectious Disease Diagnostics Sales Value by Region (2027–2032)
5.1.4 Global Respiratory Infectious Disease Diagnostics Sales Value by Region (%), 2021–2032
5.2 Global Respiratory Infectious Disease Diagnostics Sales Volume by Region
5.2.1 Global Respiratory Infectious Disease Diagnostics Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Respiratory Infectious Disease Diagnostics Sales Volume by Region (2021–2026)
5.2.3 Global Respiratory Infectious Disease Diagnostics Sales Volume by Region (2027–2032)
5.2.4 Global Respiratory Infectious Disease Diagnostics Sales Volume by Region (%), 2021–2032
5.3 Global Respiratory Infectious Disease Diagnostics Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
5.4.2 North America Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
5.5.2 Europe Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
5.6.2 Asia Pacific Respiratory Infectious Disease Diagnostics Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
5.7.2 South America Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
5.8.2 Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value and Sales Volume
6.2.1 Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
6.2.2 Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
6.3.2 United States Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Respiratory Infectious Disease Diagnostics Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
6.4.2 Europe Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Respiratory Infectious Disease Diagnostics Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
6.5.2 China Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
6.5.3 China Respiratory Infectious Disease Diagnostics Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
6.6.2 Japan Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Respiratory Infectious Disease Diagnostics Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
6.7.2 South Korea Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Respiratory Infectious Disease Diagnostics Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
6.8.2 Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Respiratory Infectious Disease Diagnostics Sales Value, 2021–2032
6.9.2 India Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
6.9.3 India Respiratory Infectious Disease Diagnostics Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Danaher
7.1.1 Danaher Company Information
7.1.2 Danaher Introduction and Business Overview
7.1.3 Danaher Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Danaher Respiratory Infectious Disease Diagnostics Product Offerings
7.1.5 Danaher Recent Developments
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Abbott Respiratory Infectious Disease Diagnostics Product Offerings
7.2.5 Abbott Recent Developments
7.3 bioMérieux
7.3.1 bioMérieux Company Information
7.3.2 bioMérieux Introduction and Business Overview
7.3.3 bioMérieux Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 bioMérieux Respiratory Infectious Disease Diagnostics Product Offerings
7.3.5 bioMérieux Recent Developments
7.4 Qingdao Hightop Biotec
7.4.1 Qingdao Hightop Biotec Company Information
7.4.2 Qingdao Hightop Biotec Introduction and Business Overview
7.4.3 Qingdao Hightop Biotec Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Qingdao Hightop Biotec Respiratory Infectious Disease Diagnostics Product Offerings
7.4.5 Qingdao Hightop Biotec Recent Developments
7.5 Roche
7.5.1 Roche Company Information
7.5.2 Roche Introduction and Business Overview
7.5.3 Roche Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Roche Respiratory Infectious Disease Diagnostics Product Offerings
7.5.5 Roche Recent Developments
7.6 QuidelOrtho
7.6.1 QuidelOrtho Company Information
7.6.2 QuidelOrtho Introduction and Business Overview
7.6.3 QuidelOrtho Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 QuidelOrtho Respiratory Infectious Disease Diagnostics Product Offerings
7.6.5 QuidelOrtho Recent Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Information
7.7.2 Thermo Fisher Scientific Introduction and Business Overview
7.7.3 Thermo Fisher Scientific Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Thermo Fisher Scientific Respiratory Infectious Disease Diagnostics Product Offerings
7.7.5 Thermo Fisher Scientific Recent Developments
7.8 Sansure
7.8.1 Sansure Company Information
7.8.2 Sansure Introduction and Business Overview
7.8.3 Sansure Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Sansure Respiratory Infectious Disease Diagnostics Product Offerings
7.8.5 Sansure Recent Developments
7.9 BD
7.9.1 BD Company Information
7.9.2 BD Introduction and Business Overview
7.9.3 BD Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 BD Respiratory Infectious Disease Diagnostics Product Offerings
7.9.5 BD Recent Developments
7.10 Hologic
7.10.1 Hologic Company Information
7.10.2 Hologic Introduction and Business Overview
7.10.3 Hologic Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Hologic Respiratory Infectious Disease Diagnostics Product Offerings
7.10.5 Hologic Recent Developments
7.11 Innovita
7.11.1 Innovita Company Information
7.11.2 Innovita Introduction and Business Overview
7.11.3 Innovita Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Innovita Respiratory Infectious Disease Diagnostics Product Offerings
7.11.5 Innovita Recent Developments
7.12 DiaSorin
7.12.1 DiaSorin Company Information
7.12.2 DiaSorin Introduction and Business Overview
7.12.3 DiaSorin Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 DiaSorin Respiratory Infectious Disease Diagnostics Product Offerings
7.12.5 DiaSorin Recent Developments
7.13 Wondfo Biotech
7.13.1 Wondfo Biotech Company Information
7.13.2 Wondfo Biotech Introduction and Business Overview
7.13.3 Wondfo Biotech Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Wondfo Biotech Respiratory Infectious Disease Diagnostics Product Offerings
7.13.5 Wondfo Biotech Recent Developments
7.14 Autobio
7.14.1 Autobio Company Information
7.14.2 Autobio Introduction and Business Overview
7.14.3 Autobio Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Autobio Respiratory Infectious Disease Diagnostics Product Offerings
7.14.5 Autobio Recent Developments
7.15 Siemens Healthineers
7.15.1 Siemens Healthineers Company Information
7.15.2 Siemens Healthineers Introduction and Business Overview
7.15.3 Siemens Healthineers Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Siemens Healthineers Respiratory Infectious Disease Diagnostics Product Offerings
7.15.5 Siemens Healthineers Recent Developments
7.16 Bio-germ
7.16.1 Bio-germ Company Information
7.16.2 Bio-germ Introduction and Business Overview
7.16.3 Bio-germ Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Bio-germ Respiratory Infectious Disease Diagnostics Product Offerings
7.16.5 Bio-germ Recent Developments
7.17 Wuhan Easy Diagnosis
7.17.1 Wuhan Easy Diagnosis Company Information
7.17.2 Wuhan Easy Diagnosis Introduction and Business Overview
7.17.3 Wuhan Easy Diagnosis Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Wuhan Easy Diagnosis Respiratory Infectious Disease Diagnostics Product Offerings
7.17.5 Wuhan Easy Diagnosis Recent Developments
7.18 Daan Gene
7.18.1 Daan Gene Company Information
7.18.2 Daan Gene Introduction and Business Overview
7.18.3 Daan Gene Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Daan Gene Respiratory Infectious Disease Diagnostics Product Offerings
7.18.5 Daan Gene Recent Developments
7.19 BioPerfectus
7.19.1 BioPerfectus Company Information
7.19.2 BioPerfectus Introduction and Business Overview
7.19.3 BioPerfectus Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 BioPerfectus Respiratory Infectious Disease Diagnostics Product Offerings
7.19.5 BioPerfectus Recent Developments
7.20 Hybribio
7.20.1 Hybribio Company Information
7.20.2 Hybribio Introduction and Business Overview
7.20.3 Hybribio Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Hybribio Respiratory Infectious Disease Diagnostics Product Offerings
7.20.5 Hybribio Recent Developments
7.21 Liferiver
7.21.1 Liferiver Company Information
7.21.2 Liferiver Introduction and Business Overview
7.21.3 Liferiver Respiratory Infectious Disease Diagnostics Sales, Revenue, Price and Gross Margin (2021–2026)
7.21.4 Liferiver Respiratory Infectious Disease Diagnostics Product Offerings
7.21.5 Liferiver Recent Developments
8 Industry Chain Analysis
8.1 Respiratory Infectious Disease Diagnostics Industrial Chain
8.2 Respiratory Infectious Disease Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Respiratory Infectious Disease Diagnostics Sales Model
8.5.2 Sales Channels
8.5.3 Respiratory Infectious Disease Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
【Table of Figures】
List of Tables
Table 1. Respiratory Infectious Disease Diagnostics Market Trends
Table 2. Respiratory Infectious Disease Diagnostics Market Drivers & Opportunities
Table 3. Respiratory Infectious Disease Diagnostics Market Challenges
Table 4. Respiratory Infectious Disease Diagnostics Market Restraints
Table 5. Global Respiratory Infectious Disease Diagnostics Revenue by Company (US$ Million), 2021–2026
Table 6. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Company (2021–2026)
Table 7. Global Respiratory Infectious Disease Diagnostics Sales Volume by Company (M Units), 2021–2026
Table 8. Global Respiratory Infectious Disease Diagnostics Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Respiratory Infectious Disease Diagnostics Price by Company (US$/Unit), 2021–2026
Table 10. Key Manufacturers Respiratory Infectious Disease Diagnostics Manufacturing Base and Headquarters
Table 11. Key Manufacturers Respiratory Infectious Disease Diagnostics Product Type
Table 12. Key Manufacturers Start of Mass Production of Respiratory Infectious Disease Diagnostics
Table 13. Global Respiratory Infectious Disease Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Respiratory Infectious Disease Diagnostics revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Respiratory Infectious Disease Diagnostics Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Respiratory Infectious Disease Diagnostics Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Respiratory Infectious Disease Diagnostics Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Type (2021–2026)
Table 20. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Type (2027–2032)
Table 21. Global Respiratory Infectious Disease Diagnostics Sales Volume by Type: 2021 vs 2025 vs 2032 (M Units)
Table 22. Global Respiratory Infectious Disease Diagnostics Sales Volume by Type (M Units), 2021–2026
Table 23. Global Respiratory Infectious Disease Diagnostics Sales Volume by Type (M Units), 2027–2032
Table 24. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Respiratory Infectious Disease Diagnostics Price by Type (US$/Unit), 2021–2026
Table 27. Global Respiratory Infectious Disease Diagnostics Price by Type (US$/Unit), 2027–2032
Table 28. Global Respiratory Infectious Disease Diagnostics Sales Value by Sample: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Respiratory Infectious Disease Diagnostics Sales Value by Sample (US$ Million), 2021–2026
Table 30. Global Respiratory Infectious Disease Diagnostics Sales Value by Sample (US$ Million), 2027–2032
Table 31. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Sample (2021–2026)
Table 32. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Sample (2027–2032)
Table 33. Global Respiratory Infectious Disease Diagnostics Sales Volume by Sample: 2021 vs 2025 vs 2032 (M Units)
Table 34. Global Respiratory Infectious Disease Diagnostics Sales Volume by Sample (M Units), 2021–2026
Table 35. Global Respiratory Infectious Disease Diagnostics Sales Volume by Sample (M Units), 2027–2032
Table 36. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Volume by Sample (2021–2026)
Table 37. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Volume by Sample (2027–2032)
Table 38. Global Respiratory Infectious Disease Diagnostics Price by Sample (US$/Unit), 2021–2026
Table 39. Global Respiratory Infectious Disease Diagnostics Price by Sample (US$/Unit), 2027–2032
Table 40. Global Respiratory Infectious Disease Diagnostics Sales Value by Testing Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Global Respiratory Infectious Disease Diagnostics Sales Value by Testing Type (US$ Million), 2021–2026
Table 42. Global Respiratory Infectious Disease Diagnostics Sales Value by Testing Type (US$ Million), 2027–2032
Table 43. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Testing Type (2021–2026)
Table 44. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Testing Type (2027–2032)
Table 45. Global Respiratory Infectious Disease Diagnostics Sales Volume by Testing Type: 2021 vs 2025 vs 2032 (M Units)
Table 46. Global Respiratory Infectious Disease Diagnostics Sales Volume by Testing Type (M Units), 2021–2026
Table 47. Global Respiratory Infectious Disease Diagnostics Sales Volume by Testing Type (M Units), 2027–2032
Table 48. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Volume by Testing Type (2021–2026)
Table 49. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Volume by Testing Type (2027–2032)
Table 50. Global Respiratory Infectious Disease Diagnostics Price by Testing Type (US$/Unit), 2021–2026
Table 51. Global Respiratory Infectious Disease Diagnostics Price by Testing Type (US$/Unit), 2027–2032
Table 52. Global Respiratory Infectious Disease Diagnostics Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 53. Global Respiratory Infectious Disease Diagnostics Sales Value by Application (US$ Million), 2021–2026
Table 54. Global Respiratory Infectious Disease Diagnostics Sales Value by Application (US$ Million), 2027–2032
Table 55. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Application (2021–2026)
Table 56. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Value by Application (2027–2032)
Table 57. Global Respiratory Infectious Disease Diagnostics Sales Volume by Application: 2021 vs 2025 vs 2032 (M Units)
Table 58. Global Respiratory Infectious Disease Diagnostics Sales Volume by Application (M Units), 2021–2026
Table 59. Global Respiratory Infectious Disease Diagnostics Sales Volume by Application (M Units), 2027–2032
Table 60. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Volume by Application (2021–2026)
Table 61. Global Respiratory Infectious Disease Diagnostics Sales Market Share in Volume by Application (2027–2032)
Table 62. Global Respiratory Infectious Disease Diagnostics Price by Application (US$/Unit), 2021–2026
Table 63. Global Respiratory Infectious Disease Diagnostics Price by Application (US$/Unit), 2027–2032
Table 64. Global Respiratory Infectious Disease Diagnostics Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 65. Global Respiratory Infectious Disease Diagnostics Sales Value by Region (US$ Million), 2021–2026
Table 66. Global Respiratory Infectious Disease Diagnostics Sales Value by Region (US$ Million), 2027–2032
Table 67. Global Respiratory Infectious Disease Diagnostics Sales Value by Region (%), 2021–2026
Table 68. Global Respiratory Infectious Disease Diagnostics Sales Value by Region (%), 2027–2032
Table 69. Global Respiratory Infectious Disease Diagnostics Sales Volume by Region (M Units): 2021 vs 2025 vs 2032
Table 70. Global Respiratory Infectious Disease Diagnostics Sales Volume by Region (M Units), 2021–2026
Table 71. Global Respiratory Infectious Disease Diagnostics Sales Volume by Region (M Units), 2027–2032
Table 72. Global Respiratory Infectious Disease Diagnostics Sales Volume by Region (%), 2021–2026
Table 73. Global Respiratory Infectious Disease Diagnostics Sales Volume by Region (%), 2027–2032
Table 74. Global Respiratory Infectious Disease Diagnostics Average Price by Region (US$/Unit), 2021–2026
Table 75. Global Respiratory Infectious Disease Diagnostics Average Price by Region (US$/Unit), 2027–2032
Table 76. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 77. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value, (US$ Million), 2021–2026
Table 78. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value, (US$ Million), 2027–2032
Table 79. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Volume, (M Units), 2021–2026
Table 80. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Volume, (M Units), 2027–2032
Table 81. Danaher Company Information
Table 82. Danaher Introduction and Business Overview
Table 83. Danaher Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 84. Danaher Respiratory Infectious Disease Diagnostics Product Offerings
Table 85. Danaher Recent Developments
Table 86. Abbott Company Information
Table 87. Abbott Introduction and Business Overview
Table 88. Abbott Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 89. Abbott Respiratory Infectious Disease Diagnostics Product Offerings
Table 90. Abbott Recent Developments
Table 91. bioMérieux Company Information
Table 92. bioMérieux Introduction and Business Overview
Table 93. bioMérieux Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 94. bioMérieux Respiratory Infectious Disease Diagnostics Product Offerings
Table 95. bioMérieux Recent Developments
Table 96. Qingdao Hightop Biotec Company Information
Table 97. Qingdao Hightop Biotec Introduction and Business Overview
Table 98. Qingdao Hightop Biotec Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 99. Qingdao Hightop Biotec Respiratory Infectious Disease Diagnostics Product Offerings
Table 100. Qingdao Hightop Biotec Recent Developments
Table 101. Roche Company Information
Table 102. Roche Introduction and Business Overview
Table 103. Roche Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 104. Roche Respiratory Infectious Disease Diagnostics Product Offerings
Table 105. Roche Recent Developments
Table 106. QuidelOrtho Company Information
Table 107. QuidelOrtho Introduction and Business Overview
Table 108. QuidelOrtho Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 109. QuidelOrtho Respiratory Infectious Disease Diagnostics Product Offerings
Table 110. QuidelOrtho Recent Developments
Table 111. Thermo Fisher Scientific Company Information
Table 112. Thermo Fisher Scientific Introduction and Business Overview
Table 113. Thermo Fisher Scientific Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 114. Thermo Fisher Scientific Respiratory Infectious Disease Diagnostics Product Offerings
Table 115. Thermo Fisher Scientific Recent Developments
Table 116. Sansure Company Information
Table 117. Sansure Introduction and Business Overview
Table 118. Sansure Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 119. Sansure Respiratory Infectious Disease Diagnostics Product Offerings
Table 120. Sansure Recent Developments
Table 121. BD Company Information
Table 122. BD Introduction and Business Overview
Table 123. BD Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 124. BD Respiratory Infectious Disease Diagnostics Product Offerings
Table 125. BD Recent Developments
Table 126. Hologic Company Information
Table 127. Hologic Introduction and Business Overview
Table 128. Hologic Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 129. Hologic Respiratory Infectious Disease Diagnostics Product Offerings
Table 130. Hologic Recent Developments
Table 131. Innovita Company Information
Table 132. Innovita Introduction and Business Overview
Table 133. Innovita Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 134. Innovita Respiratory Infectious Disease Diagnostics Product Offerings
Table 135. Innovita Recent Developments
Table 136. DiaSorin Company Information
Table 137. DiaSorin Introduction and Business Overview
Table 138. DiaSorin Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 139. DiaSorin Respiratory Infectious Disease Diagnostics Product Offerings
Table 140. DiaSorin Recent Developments
Table 141. Wondfo Biotech Company Information
Table 142. Wondfo Biotech Introduction and Business Overview
Table 143. Wondfo Biotech Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 144. Wondfo Biotech Respiratory Infectious Disease Diagnostics Product Offerings
Table 145. Wondfo Biotech Recent Developments
Table 146. Autobio Company Information
Table 147. Autobio Introduction and Business Overview
Table 148. Autobio Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 149. Autobio Respiratory Infectious Disease Diagnostics Product Offerings
Table 150. Autobio Recent Developments
Table 151. Siemens Healthineers Company Information
Table 152. Siemens Healthineers Introduction and Business Overview
Table 153. Siemens Healthineers Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 154. Siemens Healthineers Respiratory Infectious Disease Diagnostics Product Offerings
Table 155. Siemens Healthineers Recent Developments
Table 156. Bio-germ Company Information
Table 157. Bio-germ Introduction and Business Overview
Table 158. Bio-germ Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 159. Bio-germ Respiratory Infectious Disease Diagnostics Product Offerings
Table 160. Bio-germ Recent Developments
Table 161. Wuhan Easy Diagnosis Company Information
Table 162. Wuhan Easy Diagnosis Introduction and Business Overview
Table 163. Wuhan Easy Diagnosis Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 164. Wuhan Easy Diagnosis Respiratory Infectious Disease Diagnostics Product Offerings
Table 165. Wuhan Easy Diagnosis Recent Developments
Table 166. Daan Gene Company Information
Table 167. Daan Gene Introduction and Business Overview
Table 168. Daan Gene Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 169. Daan Gene Respiratory Infectious Disease Diagnostics Product Offerings
Table 170. Daan Gene Recent Developments
Table 171. BioPerfectus Company Information
Table 172. BioPerfectus Introduction and Business Overview
Table 173. BioPerfectus Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 174. BioPerfectus Respiratory Infectious Disease Diagnostics Product Offerings
Table 175. BioPerfectus Recent Developments
Table 176. Hybribio Company Information
Table 177. Hybribio Introduction and Business Overview
Table 178. Hybribio Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 179. Hybribio Respiratory Infectious Disease Diagnostics Product Offerings
Table 180. Hybribio Recent Developments
Table 181. Liferiver Company Information
Table 182. Liferiver Introduction and Business Overview
Table 183. Liferiver Respiratory Infectious Disease Diagnostics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 184. Liferiver Respiratory Infectious Disease Diagnostics Product Offerings
Table 185. Liferiver Recent Developments
Table 186. Key Raw Materials Lists
Table 187. Key Suppliers of Raw Materials Lists
Table 188. Respiratory Infectious Disease Diagnostics Downstream Customers
Table 189. Respiratory Infectious Disease Diagnostics Distributors List
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Infectious Disease Diagnostics Product Picture
Figure 2. Global Respiratory Infectious Disease Diagnostics Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 4. Global Respiratory Infectious Disease Diagnostics Sales Volume (M Units), 2021–2032
Figure 5. Global Respiratory Infectious Disease Diagnostics Sales Price (US$/Unit), 2021–2032
Figure 6. Respiratory Infectious Disease Diagnostics Report Years Considered
Figure 7. Global Respiratory Infectious Disease Diagnostics Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Respiratory Infectious Disease Diagnostics Sales Volume Ranking of Players (M Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Infectious Disease Diagnostics Revenue in 2025
Figure 10. Respiratory Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Nucleic Acid Testing Picture
Figure 12. Antigen Testing Picture
Figure 13. Antibody Testing Picture
Figure 14. Global Respiratory Infectious Disease Diagnostics Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Respiratory Infectious Disease Diagnostics Sales Value Market Share by Type, 2025 & 2032
Figure 16. Global Respiratory Infectious Disease Diagnostics Sales Volume by Type (M Units), 2021 vs 2025 vs 2032
Figure 17. Global Respiratory Infectious Disease Diagnostics Sales Volume Market Share by Type, 2025 & 2032
Figure 18. Global Respiratory Infectious Disease Diagnostics Price by Type (US$/Unit), 2021–2032
Figure 19. Throat Swab Picture
Figure 20. Nasal Swab Picture
Figure 21. Sputum Picture
Figure 22. Other Picture
Figure 23. Global Respiratory Infectious Disease Diagnostics Sales Value by Sample (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Respiratory Infectious Disease Diagnostics Sales Value Market Share by Sample, 2025 & 2032
Figure 25. Global Respiratory Infectious Disease Diagnostics Sales Volume by Sample (M Units), 2021 vs 2025 vs 2032
Figure 26. Global Respiratory Infectious Disease Diagnostics Sales Volume Market Share by Sample, 2025 & 2032
Figure 27. Global Respiratory Infectious Disease Diagnostics Price by Sample (US$/Unit), 2021–2032
Figure 28. Single Detection Picture
Figure 29. Multiple Detection Picture
Figure 30. Global Respiratory Infectious Disease Diagnostics Sales Value by Testing Type (US$ Million), 2021 vs 2025 vs 2032
Figure 31. Global Respiratory Infectious Disease Diagnostics Sales Value Market Share by Testing Type, 2025 & 2032
Figure 32. Global Respiratory Infectious Disease Diagnostics Sales Volume by Testing Type (M Units), 2021 vs 2025 vs 2032
Figure 33. Global Respiratory Infectious Disease Diagnostics Sales Volume Market Share by Testing Type, 2025 & 2032
Figure 34. Global Respiratory Infectious Disease Diagnostics Price by Testing Type (US$/Unit), 2021–2032
Figure 35. Product Picture of Hospitals
Figure 36. Product Picture of Clinical Laboratories
Figure 37. Product Picture of Others
Figure 38. Global Respiratory Infectious Disease Diagnostics Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 39. Global Respiratory Infectious Disease Diagnostics Sales Value Market Share by Application, 2025 & 2032
Figure 40. Global Respiratory Infectious Disease Diagnostics Sales Volume by Application (M Units), 2021 vs 2025 vs 2032
Figure 41. Global Respiratory Infectious Disease Diagnostics Sales Volume Market Share by Application, 2025 & 2032
Figure 42. Global Respiratory Infectious Disease Diagnostics Price by Application (US$/Unit), 2021–2032
Figure 43. North America Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 44. North America Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2025 vs 2032
Figure 45. Europe Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 46. Europe Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2025 vs 2032
Figure 47. Asia Pacific Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 48. Asia Pacific Respiratory Infectious Disease Diagnostics Sales Value by Region (%), 2025 vs 2032
Figure 49. South America Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 50. South America Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2025 vs 2032
Figure 51. Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 52. Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Value by Country (%), 2025 vs 2032
Figure 53. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Value (%), 2021–2032
Figure 54. Key Countries/Regions Respiratory Infectious Disease Diagnostics Sales Volume (%), 2021–2032
Figure 55. United States Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 56. United States Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
Figure 57. United States Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2025 vs 2032
Figure 58. Europe Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 59. Europe Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
Figure 60. Europe Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2025 vs 2032
Figure 61. China Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 62. China Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
Figure 63. China Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2025 vs 2032
Figure 64. Japan Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 65. Japan Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
Figure 66. Japan Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2025 vs 2032
Figure 67. South Korea Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 68. South Korea Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
Figure 69. South Korea Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2025 vs 2032
Figure 70. Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 71. Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
Figure 72. Southeast Asia Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2025 vs 2032
Figure 73. India Respiratory Infectious Disease Diagnostics Sales Value (US$ Million), 2021–2032
Figure 74. India Respiratory Infectious Disease Diagnostics Sales Value by Type (%), 2025 vs 2032
Figure 75. India Respiratory Infectious Disease Diagnostics Sales Value by Application (%), 2025 vs 2032
Figure 76. Respiratory Infectious Disease Diagnostics Industrial Chain
Figure 77. Respiratory Infectious Disease Diagnostics Manufacturing Cost Structure
Figure 78. Channels of Distribution (Direct Sales, and Distribution)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Respiratory Infectious Disease Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
050-5893-6232 日本
0081-50-5893-6232 グローバル
japan@qyresearch.com
